Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-710-7 | CAS number: -
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Information characterizing the toxicokinetics of Ni oxyhydroxide in experimental animals is lacking. Data on the bioaccessibility of several Nickel compounds, like Ni oxide, Ni dihydroxide and Ni oxyhydroxide in simulated biological fluids as a surrogate for bioavailability are reported within Section 7.1.1 of this IUCLID file (KMHC, 2010 and 2011). In addition, Kasprzak et al., (1983) measured the rate of dissolution of (a) colloidal nickel(II)hydroxide, (b) air-dried nickel(II)hydroxide (DRY), and (c) crystalline industrial nickel(II)hydroxide (CRST), in human blood serum, artificial lung fluid, and ammonium acetate buffer. Additional qualitative excretion and tissue distribution data in humans were reported in studies surveying occupationally exposed nickel battery workers (see Human surveillances section); however exposure was not quantitatively evaluated and thus specific evaluation of kinetics is not possible.
For inhalation absorption, Ni oxyhydroxide can be read across from nickel oxide and nickel dihydroxide. Results of bioaccessibility studies show that the release of Ni in synthetic lung fluids (simulated interstitial fluid) from Ni oxyhydroxide resembles that of Ni oxides: Ni release after 72 hours as percent of available Ni was < 1% for green and black Ni oxide and Nickel dihydroxide as well as for Ni oxyhydroxide (KMHC, 2010 and 2011). For oral absorption, Ni oxyhydroxide can be read across from Ni dihydroxide and Ni oxide since the compounds have similar Ni releases in synthetic gastric fluid (Ni dihydroxide: 26.3%, Ni oxide: 29.6% and Ni oxyhydroxide: 29.38%, respectively).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
